carvedilol has been researched along with phenylephrine in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (13.64) | 18.7374 |
| 1990's | 3 (13.64) | 18.2507 |
| 2000's | 10 (45.45) | 29.6817 |
| 2010's | 4 (18.18) | 24.3611 |
| 2020's | 2 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Graham, BR; Prichard, BN; Tomlinson, B; Walden, RJ | 1 |
| Carugo, S; Cattaneo, BM; Giannattasio, C; Grassi, G; Mancia, G; Mangoni, AA; Seravalle, G; Zanchetti, A | 1 |
| Colindres, RE; Cubeddu, LX; Fuenmayor, N; Powell, JR; Varin, F; Villagra, VG | 2 |
| Bompart, F; Graham, BR; Liu, JB; Prichard, BN; Tomlinson, B | 1 |
| Guy, S; McDermott, BJ; Riddell, JG; Shanks, RG; Tham, TC | 1 |
| Higaki, J; Kotani, N; Moriguchi, A; Nakagami, H; Ogihara, T | 1 |
| Ishikawa, Y; Sasaki, T; Uechi, M; Ueno, K; Yamamoto, T | 1 |
| Bøkenes, J; Osnes, JB; Qvigstad, E; Sandnes, D; Schiander, I; Sjaastad, I; Skomedal, T | 1 |
| Hirasawa, A; Kitagawa, Y; Koshimizu, TA; Tanoue, A; Tsujimoto, G | 1 |
| Bozhko, AA; Kanopskiĭ, SG; Staritskiĭ, AG | 1 |
| Abbott, JA; Broadstone, RV; Pyle, RL; Ward, DL | 1 |
| Bøkenes, J; Osnes, JB; Qvigstad, E; Schiander, I; Sejersted, OM; Sjaastad, I; Skomedal, T; Solberg, L | 1 |
| Gilbert, EM; Huggins, F; Munger, MA; Rondina, MT; Van Tassell, BW | 1 |
| Bajaj, N; Fan, J; Hughes, NC; Wong, EY | 1 |
| Abdulla, MH; Abdullah, NA; Johns, EJ; Sattar, MA | 1 |
| Nabbi, R; Riess, ML; Woehlck, HJ | 1 |
| Buchneva, NV; Kuz'min, OB | 1 |
| Ahmad, EA; El-Naggar, ME; Ibrahim, IAAE; Mahmoud, MF; Mohamed, RMSM; Omran, BHF; Sakr, AT | 2 |
6 trial(s) available for carvedilol and phenylephrine
| Article | Year |
|---|---|
Clinical pharmacology of carvedilol.
Topics: Adrenergic beta-Antagonists; Adult; Angiotensin II; Antihypertensive Agents; Carbazoles; Carvedilol; Dose-Response Relationship, Drug; Double-Blind Method; Hemodynamics; Humans; Labetalol; Male; Norepinephrine; Phenylephrine; Propanolamines; Vasodilator Agents | 1992 |
Alpha 1-blocking properties of carvedilol during acute and chronic administration.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Blood Pressure; Carbazoles; Carvedilol; Double-Blind Method; Drug Interactions; Female; Heart Rate; Humans; Injections, Intravenous; Isoproterenol; Male; Middle Aged; Phenylephrine; Prazosin; Propanolamines; Random Allocation; Vasodilator Agents | 1992 |
Mechanism of the vasodilatory effect of carvedilol in normal volunteers: a comparison with labetalol.
Topics: Adrenergic beta-Antagonists; Angiotensin II; Blood Pressure; Carbazoles; Carvedilol; Half-Life; Heart Rate; Humans; Isoproterenol; Labetalol; Phenylephrine; Propanolamines; Random Allocation; Vasodilation | 1987 |
Vasodilating mechanism and response to physiological pressor stimuli of acute doses of carvedilol compared with labetalol, propranolol and hydralazine.
Topics: Adrenergic beta-Antagonists; Adult; Angiotensin II; Antihypertensive Agents; Blood Pressure; Carbazoles; Carvedilol; Cold Temperature; Double-Blind Method; Exercise; Heart Rate; Hemodynamics; Humans; Hydralazine; Isoproterenol; Labetalol; Male; Middle Aged; Phenylephrine; Posture; Propanolamines; Propranolol; Vasodilator Agents | 1988 |
Clinical pharmacology of carvedilol in normal volunteers.
Topics: Adult; Angiotensin II; Blood Pressure; Carbazoles; Carvedilol; Dose-Response Relationship, Drug; Heart Rate; Humans; Isoproterenol; Kinetics; Labetalol; Male; Phenylephrine; Propanolamines; Random Allocation; Receptors, Adrenergic | 1987 |
The dose dependency of the alpha- and beta-adrenoceptor antagonist activity of carvedilol in man.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Adult; Blood Pressure; Carbazoles; Carvedilol; Double-Blind Method; Exercise; Heart Rate; Humans; Isoproterenol; Labetalol; Male; Phenylephrine; Propanolamines; Vasodilator Agents | 1995 |
16 other study(ies) available for carvedilol and phenylephrine
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Contribution of cardiovascular hypersensitivity to orthostatic hypertension and the extreme dipper phenomenon.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Aged; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Carbazoles; Cardiovascular System; Carvedilol; Female; Heart Rate; Humans; Hypertension; Isoproterenol; Norepinephrine; Phenylephrine; Posture; Propanolamines; Systole; Tilt-Table Test | 2000 |
Cardiovascular and renal effects of carvedilol in dogs with heart failure.
Topics: Administration, Oral; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Blood Pressure; Carbazoles; Carvedilol; Dog Diseases; Dogs; Echocardiography; Female; Glomerular Filtration Rate; Heart Rate; Isoproterenol; Kidney; Male; Mitral Valve Insufficiency; Phenylephrine; Propanolamines; Ventricular Remodeling | 2002 |
Carvedilol blockade of rat myocardial alpha1-adrenoceptors.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Binding, Competitive; Carbazoles; Carvedilol; Dose-Response Relationship, Drug; In Vitro Techniques; Male; Muscle Contraction; Myocardial Contraction; Norepinephrine; Papillary Muscles; Phenylephrine; Prazosin; Propanolamines; Radioligand Assay; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, beta; Tritium | 2003 |
Carvedilol selectively inhibits oscillatory intracellular calcium changes evoked by human alpha1D- and alpha1B-adrenergic receptors.
Topics: Adrenergic Antagonists; Calcium; Carbazoles; Carvedilol; Cell Line; Humans; Kidney; Mitogen-Activated Protein Kinases; Norepinephrine; Phenylephrine; Propanolamines; Protein Binding; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, beta; Stimulation, Chemical | 2004 |
[Correction of baroreflex sensitivity impairment and efficacy of prevention of sudden arrhythmic death in patients with postinfarction left ventricular dysfunction].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Antihypertensive Agents; Arrhythmias, Cardiac; Atenolol; Baroreflex; Bisoprolol; Carbazoles; Carvedilol; Data Interpretation, Statistical; Death, Sudden, Cardiac; Drug Therapy, Combination; Echocardiography; Electrocardiography; Female; Humans; Male; Metoprolol; Middle Aged; Myocardial Infarction; Perindopril; Phenylephrine; Propanolamines; Time Factors; Ventricular Dysfunction, Left | 2004 |
Hemodynamic effects of orally administered carvedilol in healthy conscious dogs.
Topics: Administration, Oral; Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Blood Pressure; Carbazoles; Carvedilol; Dogs; Heart Failure; Heart Rate; Hemodynamics; Isoproterenol; Phenylephrine; Propanolamines; Pulmonary Wedge Pressure; Random Allocation | 2005 |
Carvedilol blockade of alpha1- and beta-adrenoceptor induced inotropic responses in rats with congestive heart failure.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Carbazoles; Carvedilol; Dose-Response Relationship, Drug; Heart Failure; In Vitro Techniques; Isoproterenol; Male; Myocardial Contraction; Myocardial Infarction; Norepinephrine; Papillary Muscles; Phenylephrine; Propanolamines; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, beta; Vasoconstrictor Agents; Vasodilator Agents | 2005 |
Carvedilol increases blood pressure response to phenylephrine infusion in heart failure subjects with systolic dysfunction: evidence of improved vascular alpha1-adrenoreceptor signal transduction.
Topics: Adrenergic alpha-Agonists; Adrenergic Antagonists; Adult; Aged; Aged, 80 and over; Blood Pressure; Carbazoles; Carvedilol; Female; Heart Failure; Humans; Male; Middle Aged; Phenylephrine; Propanolamines; Prospective Studies; Receptors, Adrenergic, alpha-1; Signal Transduction; Systole; Ventricular Dysfunction | 2008 |
Assessing the matrix effects of hemolyzed samples in bioanalysis.
Topics: Atorvastatin; Benzodiazepines; Blood; Carbazoles; Carvedilol; Chemistry Techniques, Analytical; Chromatography, Liquid; Hemolysis; Heptanoic Acids; Microfluidics; Olanzapine; Pharmaceutical Preparations; Phenylephrine; Propanolamines; Pyrroles; Solid Phase Extraction; Spectrometry, Mass, Electrospray Ionization | 2009 |
The effect of losartan and carvedilol on renal haemodynamics and altered metabolism in fructose-fed Sprague-Dawley rats.
Topics: Angiotensin II; Animals; Body Weight; Carbazoles; Carvedilol; Fructose; Glucose Tolerance Test; Hemodynamics; Insulin Resistance; Kidney; Losartan; Male; Norepinephrine; Phenylephrine; Propanolamines; Rats; Rats, Sprague-Dawley; Vasoconstrictor Agents | 2012 |
Angiotensin-receptor-blocker-induced refractory hypotension responds to methylene blue.
Topics: Aged; Angiotensin Receptor Antagonists; Carbazoles; Carvedilol; Citalopram; Crystalloid Solutions; Diabetes Mellitus, Type 2; Drug Resistance; Female; Gastric Bypass; Humans; Hypotension; Isotonic Solutions; Obesity, Morbid; Phenylephrine; Preoperative Care; Propanolamines; Tetrazoles; Valine; Valsartan | 2012 |
[Effect of the third generation beta-blockers on ion-regulating renal function in rats with heart failure model].
Topics: Adrenergic beta-Antagonists; Animals; Benzopyrans; Carbazoles; Carvedilol; Disease Models, Animal; Diuresis; Ethanolamines; Heart Failure; Heart Rate; Kidney; Kidney Function Tests; Male; Nebivolol; Phenylephrine; Physical Exertion; Potassium; Propanolamines; Rats; Sodium; Water-Electrolyte Balance | 2012 |
Mitigation of dexamethasone-induced nephrotoxicity by modulating the activity of adrenergic receptors: Implication of Wnt/β-arrestin2/β-catenin pathway.
Topics: Acute Kidney Injury; Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-1 Receptor Antagonists; Animals; Anti-Inflammatory Agents; beta-Arrestin 2; Carvedilol; Dexamethasone; Male; Phenylephrine; Rats; Rats, Wistar; Receptors, Adrenergic; Wnt Signaling Pathway | 2022 |
Carvedilol ameliorates dexamethasone-induced myocardial injury in rats independent of its action on the α1-adrenergic receptor.
Topics: Adrenergic beta-Antagonists; Animals; Carbazoles; Cardiotoxicity; Carvedilol; Dexamethasone; Phenylephrine; Propanolamines; Propranolol; Rats | 2022 |